C-reactive protein as a marker of chronic inflammation in uremic patients

Blood Purification

Volumn 18, Issue 3, 2000, Pages 183-190

  Panichi, Vincenzo ^a,c   Migliori, Massimiliano ^a   De Pietro, Stefano ^a   Taccola, Daniele ^a   Blanchi, Anna Maria ^a   Norpoth, Maria ^a   Giovannini, Luca ^a   Palla, Roberto ^a   Tetta, Ciro ^b  

^a UNIVERSITY OF PISA   (Italy)

^b Cyberonics Inc   (Italy)

^c Dipartimento Medicina Interna   (Italy)

Author keywords

Biocompatibility; C reactive protein; Chronic inflammation; Hemodiafiltration; Interleukin 6

Indexed keywords

C REACTIVE PROTEIN;

CARDIOVASCULAR RISK; CHRONIC INFLAMMATION; DIALYSATE; GENE LOCATION; HEMODIALYSIS; HUMAN; MYOCARDIAL DISEASE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; RISK FACTOR; UREMIA;

EID: 0033854236     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014417     Document Type: Review

References (36)

1. Linder A, Charra B, Sherrard DJ, Schribner BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974;290:697-701.
2. Ma KW, Greene EL, Raij L: Cardiovascular risk factors in chronic renal failure and hemodialysis populations. Am J Kidney Dis 1992;19:505-513.
3. Lamiere N, Bernaert P, Lambert MC, Vijt D: Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis. Kidney Int 1994;46(suppl 48):S31-S38.
4. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999;55:1899-1911.
5. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-979.
6. Gewurz H, Mold C, Siegel J: C-reactive protein and the acute phase response. Adv Intern Med 1982;27:345-372.
7. Kushner I: The phenomenon of the acute phase response. Ann NY Acad Sci 1982; 389:39-48.
8. Mackiewicz A, Speroff T, Ganapathi MK: Effects of cytokine combinations on acute phase proteins production in two hepatoma cell lines. J Immunol 1991; 146:3032-3037.
9. Ganapathi MK, May LT, Schultz D, et al: Role of interleukin-6 in regulating synthesis of C-reactive protein and serum amyloid A in human hepatoma cell lines. Biochem Biophys Res Commun 1988;157:271-277.
10. Steel DM, Whitehead AS: The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994;15:81-88.
11. Ballou SP, Kushner I: C-reactive protein and the acute phase response. Adv Intern Med 1992;37:313-336.
12. Christenson RH, Hassan ME, Azzazy HM: Biochemical markers of the acute coronary syndromes. Clin Chem 1998; 44:1855-1864.
13. Mendal MA, Patel P, Ballam L, Strachan D, Northfield TC: C-reactive protein and its relation to cardiovascular risk factors: A population-based cross-sectional study. BMJ 1996;312:1061-1065.
14. Liuzzo G, Biasucci LM, Gallimore JR, et al: The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-424.
15. Maseri A: Inflammation, atherosclerosis and ischemic events - Exploring the hidden side of the moon. N Engl J Med 1997;336:1014-1016.
16. Nieminen MS, Mattila K, Valtonen V: Infection and inflammation as risk factors for myocardial infarction. Eur Heart J 1993;14:6-12.
17. Mendal MA, Patel P, Ballam L, Strachan D, Northfield TC: C-reactive protein and its relation to cardiovascular risk factors: A population-based cross-sectional study. BMJ 1996;312:1061-1065.
18. Lagrand WK, Niessen JWM, Wolbink GJ, Jaspar EH, Visser CA, Verheug FWA, Mejer CJLM, Hack CE: C-reactive protein sites colocalized with complement in human hearts during acute myocardial infarction. Circulation 1997;95: 97-103.
19. Lagrand WK, Cees A, Visser CA, Hermens WT, Niessen JWM, Freek WA, Verheug FWA, Wolbink GJ, Hack CE: C-reactive protein as a cardiovascular risk. More than an epiphenomenon? Circulation 1999;100:96-102.
20. Herbelin A, Urena P, Nguyen AT, Zingraff J, Descamps-Latsha B: Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int 1991;39:954-960.
21. Nakahama H, Tanaka Y, Shirai D, Miyazaki M, Imaj N, Yokokawa T, Okada M, Kubori S: Plasma interleukin-6 levels in continuous ambulatory peritoneal dialysis and hemodialysis patients. Nephron 1992;61:132-134.
22. Cavaillon JM, Poignet JL, Fitting C, Delons S: Serum interleukin-6 in long-term hemodialyzed patients. Nephron 1992; 60:307-313.
23. Kaysen G, Rathore V, Shearer GC, Depner TA: Mechanisms of hypoalbuminemia in hemodialysis patients. Kidney Int 1995;48:510-516.
24. Barany P, Divino Fiho JC, Bergstrom J: High C-reactive protein is a strong predictor to erythropoietin in hemodialysis patients. Am J Kidney Dis 1997;29:565-568.
25. Haubitz M, Brunkhorst R, Wrenger E, Foese P, Shultze M, Koch KM: Chronic induction of C-reactive protein by hemodialysis, but not by peritoneal dialysis therapy. Perit Dial Int 1996;16:158-162.
26. Bergstrom J, Heimburger O, Lindholm B, Qureshi AR: Elevated serum C-reactive protein is a strong predictor of increased mortality and low serum albumin in hemodialysis patients. J Am Soc Nephrol 1995;6:573.
27. Iseki K, Tozawa M, Yoshi S, Fukiyama K: Serum C-reactive protein and risk of death in chronic dialysis patients. Nephrol Dial Transplant 1999;14:1965-1960.
28. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55:648-658.
29. Ikizler TA, Wingard RL, Harvell J, Shyr Y, Hakim RM: Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: A prospective study. Kidney Int 1999;55: 1945-1951.
30. Kaizu Y, Kimura M, Yoneyama T, Miyajl K, Hibi I, Kumagai H: Interleukin-6 may mediate malnutrition in chronic hemodialysis patients. Am J Kidney Dis 1998;31:93-100.
31. Pereira BJG, Snodgrass B, King AJ, Hogan P: Diffusive and convective transfer of cytokine-inducing bacterial products across hemodialysis membranes. Kidney Int 1995;47:603-610.
32. Lonnemann G: Dialysate bacteriological quality and the permeability of dialyzer membranes to pyrogens. Kidney Int 1993;43(suppl 41):S195-S200.
33. Tielmans C, Husson C, Schurmans T, Gastadello K, Madhoun P, Delville JP, Marchant A, Goldman M: Effects of ultrapure and non-sterile dialysate on the inflammatory response during in vitro hemodialysis. Kidney Int 1996;49:236-243.
34. Panichi V, De Pietro S, Andreini B, Migliori M, Tessore V, Taccola D, Rindi P, Palla R, Tetta C: Cytokine production in hemodiafiltration: A multicentre study. Nephrol Dial Transplant 1998;13:1452-1459.
35. Panichi V, Tetta C, Rindi P, Palla R, Lonnemann G: Plasma C-reactive protein is linked to backfiltration associated interleukin-6 production. ASAIO J 1998; 44:M415-M417.
36. Panichi V, Migliori M, De Pietro S, Taccola D, Metelli MR, Perez R, MR, Palla R, Rindi P, Cristofani R, Tetta C: Plasma C-reactive protein in hemodialysis patients: a cross-sectional and longitudinal survey. Blood Purif 2000;18:30-36.